ABT — ABBOTT LABORATORIES
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1800 ·
Last close
$98.83
Market Cap
$171.01B
52W High
$132.39
52W Low
$81.39
ADV30
8,336,434
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 11,164,000,000 | 6,274,000,000 | 1,345,000,000 | 1,077,000,000 | 110,429,000,000 | 6,803,000,000 | 57,728,000,000 |
| Dec 2025 | 11,459,000,000 | 6,537,000,000 | 2,251,000,000 | 1,776,000,000 | 86,713,000,000 | 8,522,000,000 | 33,942,000,000 |
| Sep 2025 | 11,369,000,000 | 6,294,000,000 | 2,057,000,000 | 1,644,000,000 | 84,181,000,000 | 7,511,000,000 | 32,917,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$9,464,000,000
Investing CF
$-22,276,000,000
Financing CF
$13,059,000,000
CapEx
$-2,086,000,000
Dividends Paid
$-4,188,000,000
Buybacks
$-793,000,000
EPS Diluted TTM
$3.09
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$49,956,000,000
Inventory
$6,989,000,000
Receivables
$11,224,000,000
ST Investments
$492,000,000
EBIT TTM
$8,673,000,000
Pretax Income TTM
$8,137,000,000
Interest Exp TTM
$536,000,000
Analysts
24
Yahoo Snapshot (yfinance, live)
Total Revenue
$46,584,999,936
EBITDA
$11,681,000,448
Free Cash Flow
$7,209,124,864
Enterprise Value
$204,181,569,536
Total Cash
$5,602,999,808
Total Debt
$32,719,998,976
Shares Out
1,730,383,296
Trailing EPS
$3.09
Book Value
$29.54
ROE
10.6%
ROA
5.3%
Div Yield
2.47%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,328,000,000 | 8,053,000,000 | 6,524,000,000 | 86,713,000,000 | 33,942,000,000 | 52,130,000,000 | 9,566,000,000 |
| Dec 2024 | 41,950,000,000 | 6,825,000,000 | 13,402,000,000 | 81,414,000,000 | 33,513,000,000 | 47,664,000,000 | 8,558,000,000 |
| Dec 2023 | 40,109,000,000 | 6,478,000,000 | 5,723,000,000 | 73,214,000,000 | 34,387,000,000 | 38,603,000,000 | 7,261,000,000 |
| Dec 2022 | 43,653,000,000 | 8,362,000,000 | 6,933,000,000 | 74,438,000,000 | 37,533,000,000 | 36,686,000,000 | 9,581,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$6.07
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $100.00 · spot: $98.83 · call volume: 1,205 · put volume: 279
Expected Move to 2026-12-18:
±$10.55
(10.67%) —
implied range
$88.28 –
$109.38
· ATM straddle on $100.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PFE | PFIZER INC | $162.55B | $28.52 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $132.51B | $522.81 | — |
| NONOF | NOVO NORDISK A S | $127.58B | $38.15 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $127.47B | $62.40 | — |
| NVO | NOVO NORDISK A S | $126.77B | $37.91 | — |
News headlines (Yahoo Finance, 1h cache)
More Brands Break the US$1 Million Mark as Lazada Celebrates Partner Growth
2026-10-01 03:00 · Yahoo
Abbott launches Freenome’s colorectal cancer screening test
2026-09-30 14:58 · Yahoo
Abbott hosts conference call for third-quarter earnings
2026-09-30 13:00 · Yahoo
Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
2026-09-30 12:00 · Yahoo
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth
2026-09-29 13:26 · Yahoo
Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter Internation
2026-09-28 10:24 · Yahoo
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
2026-09-27 23:16 · Yahoo
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
2026-09-24 21:00 · Yahoo
Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery
2026-09-24 13:10 · Yahoo
TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher
2026-09-24 12:59 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.